I agree that this site is using cookies. You can find further informations here.
X
Thiebaut‐Bertrand, Anne
53  results:
Search for persons X
?
1

Risk factors of BK viral hemorrhagic cystitis in allogenic ..:

Kaphan, Eléonore ; Germi, Raphaele ; Bailly, Sébastien...
Transplant Infectious Disease.  23 (2021)  5 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
2

Optimization of voriconazole therapy for treatment of invas..:

Gautier‐Veyret, Elodie ; Thiebaut‐Bertrand, Anne ; Roustit, Matthieu...
British Journal of Clinical Pharmacology.  87 (2020)  6 - p. 2534-2541 , 2020
Link: https://doi.org/10.1111/..
 
?
3

Inflammation is a potential risk factor of voriconazole ove..:

Gautier‐Veyret, Elodie ; Truffot, Aurélie ; Bailly, Sébastien...
Fundamental & Clinical Pharmacology.  33 (2018)  2 - p. 232-238 , 2018
Link: https://doi.org/10.1111/..
 
?
4

Minimum inhibitory concentrations of amphotericin B against..:

Murat, Jean‐Benjamin ; Lebeau, Bernadette ; Chumpitazi, Bernabé...
Mycoses.  56 (2012)  1 - p. 56-60 , 2012
Link: https://doi.org/10.1111/..
 
?
5

Early picc-line infections in non-neutropenic patients are ..:

Volpari, Victoria ; Gallouche, Meghann ; Caspar, Yvan...
Infectious Diseases Now.  54 (2024)  2 - p. 104842 , 2024
Link: https://doi.org/10.1016/..
 
?
6

P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KM..:

Kim, Rathana ; Bergugnat, Hugo ; Pasquier, Florence...
HemaSphere.  7 (2023)  S3 - p. e7342363 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Comment on 'Therapeutic drug monitoring-guided treatment ve..:

Gautier-Veyret, Elodie ; Thiebaut-Bertrand, Anne ; Stanke-Labesque, Françoise
International Journal of Antimicrobial Agents.  62 (2023)  2 - p. 106853 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Variability of Isavuconazole Trough Concentrations during L..:

Bolcato, Léa ; Thiebaut-Bertrand, Anne ; Stanke-Labesque, Françoise.
Journal of Clinical Medicine.  11 (2022)  19 - p. 5756 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Correction: Infectious complications of targeted drugs and ..:

Maschmeyer, Georg ; Bullinger, Lars ; Garcia-Vidal, Carolina...
Leukemia.  36 (2022)  5 - p. 1450-1450 , 2022
Link: https://doi.org/10.1038/..
 
?
10

Infectious complications of targeted drugs and biotherapies..:

Maschmeyer, Georg ; Bullinger, Lars ; Garcia-Vidal, Carolina...
Leukemia.  36 (2022)  5 - p. 1215-1226 , 2022
Link: https://doi.org/10.1038/..
 
?
11

Infections associated with immunotherapeutic and molecular ..:

on behalf of the European Conference on Infections in Leukemia (ECIL) ; Maschmeyer, Georg ; De Greef, Julien...
Leukemia.  33 (2019)  4 - p. 844-862 , 2019
Link: https://doi.org/10.1038/..
 
?
12

Virus d'Epstein-Barr et syndromes lymphoprolifératifs post-..:

Lupo, Julien ; Thiebaut-Bertrand, Anne ; Epaulard, Olivier..
Revue Francophone des Laboratoires.  2019 (2019)  515 - p. 26-35 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Inhibition of Voriconazole Metabolism by Meropenem: A Role ..:

Truffot, Aurélie ; Thiebaut-Bertrand, Anne ; Chapuis, Claire..
Clinical Infectious Diseases.  66 (2018)  10 - p. 1643-1644 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Apport du séquençage nouvelle génération au typage MLST de ..:

Charpentier, Eléna ; Garnaud, Cécile ; Wintenberger, Claire...
Journal de Mycologie Médicale.  27 (2017)  3 - p. e9-e10 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Added Value of Next-Generation Sequencing for Multilocus Se..:

Charpentier, Elena ; Garnaud, Cécile ; Wintenberger, Claire...
Emerging Infectious Diseases.  23 (2017)  8 - p. 1237-1245 , 2017
Link: https://doi.org/10.3201/..
 
1-15